Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
出版年份 2021 全文链接
标题
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
作者
关键词
-
出版物
Lancet Rheumatology
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-08-07
DOI
10.1016/s2665-9913(21)00222-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021
- (2021) Kamal Abu Jabal et al. Eurosurveillance
- COVID-19: Immunology, Immunopathogenesis and Potential Therapies
- (2021) Asha Bhardwaj et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Sex difference in the immunogenicity of the quadrivalent Human Papilloma Virus vaccine: Systematic review and meta-analysis
- (2021) Lafi Aldakak et al. VACCINE
- Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases
- (2021) Robert Spiera et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
- (2021) Nicholas A Kennedy et al. GUT
- SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort
- (2021) Zoé L. E. van Kempen et al. JAMA Neurology
- Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease
- (2021) Rebecca H Haberman et al. ANNALS OF THE RHEUMATIC DISEASES
- Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
- (2021) Laura Boekel et al. Lancet Rheumatology
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity of The Influenza Vaccine in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis
- (2020) Jackie Nguyen et al. Multiple Sclerosis and Related Disorders
- Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis
- (2016) Mathilde Pugès et al. RHEUMATOLOGY
- Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis
- (2016) Zhengfa Liao et al. PLoS One
- False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies
- (2014) Mark E. Glickman et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Vaccine Responses in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol: Results from a Single-blind Randomized Phase IV Trial
- (2014) A. J. Kivitz et al. JOURNAL OF RHEUMATOLOGY
- Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Charlotte Hua et al. ARTHRITIS CARE & RESEARCH
- Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors
- (2011) Meliha Crnkic Kapetanovic et al. ARTHRITIS AND RHEUMATISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started